Medinotec Inc. Stock

Equities

MDNC

US58500G1076

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets 5-day change 1st Jan Change
- USD -.--% Intraday chart for Medinotec Inc. -.--% -.--%
Sales 2022 - Sales 2023 1 Capitalization 58.67M
Net income 2022 - Net income 2023 - EV / Sales 2022 * -
Net cash position 2022 * - Net cash position 2023 * - EV / Sales 2023 * -
P/E ratio 2022 *
-
P/E ratio 2023 *
-
Employees 29
Yield 2022 *
-
Yield 2023 *
-
Free-Float 15.61%
More Fundamentals * Assessed data
Dynamic Chart
1 year
0.00
Extreme 0
5.00
3 years
0.00
Extreme 0
5.00
5 years
0.00
Extreme 0
5.00
10 years
0.00
Extreme 0
5.00
More quotes
Managers TitleAgeSince
Founder 44 21-04-25
Director of Finance/CFO 38 21-04-25
Members of the board TitleAgeSince
Director/Board Member 66 22-06-12
Director/Board Member 53 22-06-12
Director of Finance/CFO 38 21-04-25
More insiders
Medinotec Inc., through its primary investment in DISA Medinotec (Medinotec), is engaged in medical device manufacturing and distribution. Medinotec has a tracheal non-occlusive airway dilation technology and medical device that designs, manufactures and distributions. Its product includes Trachealator, Cape Cross PTCA Catheter, Cape Cross NC Catheter, Lamprey Suction Dissector, Aortic Perfusion and Dilatation Catheter, Micro CTO Catheter, and Tracheal Stent. The products developed are sold through a network of distributors in many parts of the world and through a direct sales force in South Africa and the United States of America.
More about the company